Jessica Chubak, PhD, is an epidemiologist who works to improve cancer diagnosis, treatment, control, and survivorship. She contributes to several national collaborations that are finding practical, efficient, effective ways to screen for cancer, especially colorectal cancer. She also studies how common medications affect cancer risk and recurrence. Intrigued by how pets positively affect health, Dr. Chubak is studying animal-assisted activities in clinics and hospitals where children get treated for cancer. Dr. Chubak’s methodological research focuses on the use of administrative and electronic health record data in epidemiologic and health services studies.
Dr. Chubak joined KPWHRI in 2007, bringing expertise in epidemiologic methods, pharmacoepidemiology, and cancer. Awarded a Fulbright graduate student grant, Dr. Chubak pursued her master's degree in bioethics and health law in New Zealand before completing her PhD in Epidemiology at the University of Washington (UW). Dr. Chubak is an affiliate associate professor in the Department of Epidemiology at the UW School of Public Health, where she enjoys guest-lecturing and getting to work with students.
Epidemiology; colorectal cancer; medication use; survivorship; recurrence; secondary prevention; quality of life; automated data collection; screening; animal-assisted activities; survivorship
Screening
Cancer risk and use of common medications
Ghai NR, Jensen CD, Merchant SA, Schottinger JE, Lee JK, Chubak J, Kamineni A, Halm EA, Skinner CS, Haas JS, Green BB, Cannizzaro NT, Schneider JL, Corley DA Primary Care Provider Beliefs and Recommendations About Colorectal Cancer Screening in Four Healthcare Systems 2020 Nov;13(11):947-958. doi: 10.1158/1940-6207.CAPR-20-0109. Epub 2020-07-15. PubMed
A'mar T, Beatty JD, Fedorenko C, Markowitz D, Corey T, Lange J, Schwartz SM, Huang B, Chubak J, Etzioni R. Correction: incorporating breast cancer recurrence events into population-based cancer registries using medical claims: cohort study. JMIR Cancer. 2020;6(2):e23821. doi: 10.2196/23821. PubMed
A'mar T, Beatty JD, Fedorenko C, Markowitz D, Corey T, Lange J, Schwartz SM, Huang B, Chubak J, Etzioni R Incorporating Breast Cancer Recurrence Events Into Population-Based Cancer Registries Using Medical Claims: Cohort Study 2020 Aug 17;6(2):e18143. doi: 10.2196/18143. Epub 2020-08-17. PubMed
Chubak J, Anderson ML, Cook AJ, Murphy CC, Jackson ML, Green BB Methodological considerations in calculating and analyzing proportion of time covered as a measure of longitudinal cancer screening adherence 2020 Aug;29(8):1549-1556. doi: 10.1158/1055-9965.EPI-20-0388. Epub 2020-05-28. PubMed
Reding KW, Aragaki AK, Cheng RK, Barac A, Wassertheil-Smoller S, Chubak J, Limacher MC, Hundley WG, D'Agostino R, Vitolins MZ, Brasky TM, Habel LA, Chow EJ, Jackson RD, Chen C, Morgenroth A, Barrington WE, Banegas M, Barnhart M, Chlebowski RT Cardiovascular Outcomes in Relation to Antihypertensive Medication Use in Women with and Without Cancer: Results from the Women's Health Initiative 2020 Aug;25(8):712-721. doi: 10.1634/theoncologist.2019-0977. Epub 2020-04-06. PubMed
Hua X, Newcomb PA, Chubak J, Malen RC, Ziebell R, Kamineni A, Zhu LC, Upton MP, Wurscher MA, Thomas SS, Newman H, Hardikar S, Burnett-Hartman AN Associations between molecular characteristics of colorectal serrated polyps and subsequent advanced colorectal neoplasia 2020 Jul;31(7):631-640. doi: 10.1007/s10552-020-01304-1. Epub 2020-05-01. PubMed
Zheng Y, Corley DA, Doubeni C, Halm E, Shortreed SM, Barlow WE, Zauber A, Tosteson TD, Chubak J ANALYSES OF PREVENTIVE CARE MEASURES WITH INCOMPLETE HISTORICAL DATA IN ELECTRONIC MEDICAL RECORDS: AN EXAMPLE FROM COLORECTAL CANCER SCREENING 2020 Jun;14(2):1030-1044. doi: 10.1214/20-aoas1342. Epub 2020-06-29. PubMed
The findings can help guide colorectal cancer screening decisions later in life.
Understanding emergency department use among adolescent and young adult cancer survivors can help address care gaps.
How KPWHRI is contributing to better cancer screening and better outcomes for patients.